2026 capital expenditure plan approximately $2.0B
Company: Core Scientific
The claim, verbatim
2026 capital expenditure plan is approximately $2.0B assuming no new customer contract, with expectations subject to change based on timing of new customer contracts
Source (primary)
core-scientific 8-K exhibit (q1fy26earningsdeck.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-09-08)Live source ↗
Quote: “~$2B 2026 capex... 2026 CapEx plan of ~$2B, as of May 6, 2026, assumes no new customer contract”
How we checked this
Checked on September 19, 2026. The cited source supports every part of this claim.
The CapEx footnote states the ~$2B 2026 plan assumes no new customer contract and may change with contract timing.
Confirmed in the source:
- 2026 capital expenditure plan is ~$2B
- The plan assumes no new customer contract
- CapEx expectations may change based on timing of new customer contracts
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000162828026031246/q1fy26earningsdeck.htm) in full (14,867 characters, retrieved September 8, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (q1fy26earningsdeck.htm)
Quote: “~$2B 2026 capex... 2026 CapEx plan of ~$2B, as of May 6, 2026, assumes no new customer contract”